CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The MAD-CoV-2 project aims to develop innovative therapies for COVID-19 by engineering human tissues and identifying key host factors involved in viral replication. The project brings together experts to translate scientific findings into practical solutions for current and future coronavirus outbreaks.
The SARS-CoV-2 pandemic has become an unprecedented burden to public health, our civil societies and the global economy.
To provide frontline therapies for COVID-19 and future corona virus outbreaks requires a concerted effort of different disciplines, technologies, high security labs, and rapid translation of scientific findings to highly innovative and “hungry” SME partners.
For the MAD-CoV-2 project we have assembled a multidisciplinary team of world-leading researchers and innovative industr…
STATENS VETERINAERMEDICINSKA ANSTALT
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
France, PARIS
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Austria, Wien
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Germany, Giessen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Austria, Wien
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
